Title: Chief Science Officer, Tenured Professor of Anatomy and Retired Emeritus
Company: Dragonfly Foundation for Research and Development, Mercer University School of Medicine
Location: Macon, Georgia, United States
Henry Young, Tenured Professor of Anatomy and Retired Emeritus at Mercer University School of Medicine, has been recognized by Marquis Who’s Who Top Doctors for dedication, achievements, and leadership in stem cell research.
With both his parents suffering from chronic diseases, Dr. Young knew that he wanted to enter a field where he could help others. He earned a Bachelor of Science from The Ohio State University in 1974, a Master of Science in zoology from the University of Arkansas in 1977, a PhD from Texas Tech University in 1983, and completed postdoctoral work at Case Western Reserve University from 1983 to 1987. In 1975, he started studying the regeneration of tissues during limb regeneration in the adult terrestrial salamander and hypothesized that if adult terrestrial salamanders can regenerate limbs, humans may be able to as well. He has spent his entire research career studying this phenomenon and concluded that humans can regenerate their own damaged tissues using adult-derived stem cells. Dr. Young has spent his career working on categorizing them, discovering cell service markers, differentiating potential, and re-culturing them. He went into animal models with different chronic diseases and is now working on using the cells with humans. Though both his parents died before benefitting from stem cell research, Dr. Young is confident his work can still help others.
Dr. Young worked as an instructor of biochemistry at Rush-Presbyterian-St. Luke’s Medical Center, now Rush University Medical Center, from 1987 to 1988 before taking his talents to Mercer University. There, he worked as a professor of anatomy, anesthesiology, obstetrics and gynecology, pediatrics, and surgery until 2016, at which time he assumed the titles of tenured professor of anatomy and retired emeritus. Dr. Young served as a staff scientist for Dragonfly Foundation for Research and Development from 1976 until 2016, when he advanced to chief science officer. In this role, Dr. Young has IRB-approved clinical trials for Amyotrophic Lateral Sclerosis-Laboratory Abnormalities of Undetermined Significance (ALS-LAUS), Multiple Sclerosis (MS), Parkinson Disease (PD), Chronic Obstructive Pulmonary Disease (COPD), and Systemic Lupus Erythematosus (SLE) by utilizing adult-derived stem cells.
Throughout the course of his career, Dr. Young has made 20 scientific discoveries, won 96 awards, published 69 manuscripts, and has 30 patent submissions, among other accomplishments. He holds membership with esteemed organizations including, but not limited to, the American Association of Anatomists, Cambridge Healthtech Associates, Gold Humanism Honor Society, Federation of American Societies for Experimental Biology, Society for In Vitro Biology, and The Wound Healing Society. He has been lauded with numerous awards including the Albert Nelson Marquis Lifetime Achievement Award and has been featured in multiple editions of Who’s Who in America, Who’s Who in American Education, Who’s Who in Medicine and Healthcare, Who’s Who in Science and Engineering, and Who’s Who in the South and Southwest.
For more information, please visit:
Contact Dr. Young: